Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Interdialytic Serum Bicarbonate Correction on Vascular Calcification in Prevalent Hemodialysis Patients

NCT07765459 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07765459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07765459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Interdialytic Serum Bicarbonate Correction on Vascular Calcification in Prevalent Hemodialysis Patients
Lead sponsor
Ain Shams University
Phase
Phase 1
Overall status
Completed
Start date
September 1, 2023
Completion date
February 29, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease (esrd), metabolic acidosis